Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 34 results.
User Information
Export Records
  1. 1.   Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine
  2. Odio, Camila D; Lowman, Kelsey E; Law, Melissa; Aogo, Rosemary A; Hunsberger, Sally; Wood, Brad J; Kassin, Michael; Levy, Elliot; Callier,Viviane; Firdous, Saba; Hasund, Chloe M; Voirin, Charlie; Kattappuram, Robbie; Yek, Christina; Manning, Jessica; Durbin, Anna; Whitehead, Stephen S; Katzelnick, Leah C
  3. BMC infectious diseases. 2023, May 23; 23(1): 345.
  1. 2.   Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque
  2. Virnik, Konstantin; Zhou, Wenshuo; Medvedev, Alexei; Walsh, Gabrielle; Perry-Anderson, Jasper; Majam, Victoria; Felber,Barbara; Kumar, Sanjai; Berkower, Ira
  3. Biochemical and biophysical research communications. 2021, Nov 5; 577: 58-63.
  1. 3.   Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors
  2. Virnik, Konstantin; Nesti, Edmund; Dail, Cody; Hockenbury, Max; Ni, Yisheng; Felber, Barbara; Schief, William R; Berkower, Ira
  3. Vaccine. 2017, May 31; 35(24): 3272-3278.
  1. 4.   Envelope-Modified Single-Cycle Simian Immunodeficiency Virus Selectively Enhances Antibody Responses and Partially Protects against Repeated, Low-Dose Vaginal Challenge
  2. Alpert, M. D.; Rahmberg, A. R.; Neidermyer, W.; Ng, S. K.; Carville, A.; Camp, J. V.; Wilson, R. L.; Piatak, M.; Mansfield, K. G.; Li, W. J.; Miller, C. J.; Lifson, J. D.; Kozlowski, P. A.; Evans, D. T.
  3. Journal of Virology. 2010, Oct; 84(20): 10748-10764.
  1. 5.   Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression
  2. Witko, S. E.; Johnson, J. E.; Kalyan, N. K.; Felber, B. K.; Pavlakis, G. N.; Sidhu, M. K.; Hendry, R. M.; Udem, S. A.; Parks, C. L.
  3. Journal of Virological Methods. 2010, Mar; 164(1-2): 43-50.
  1. 6.   Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys
  2. Wang, H. B.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Abe, S.; Bao, L. L.; Mizuki, N.; Ichino, M.; Klinman, D.; Okuda, K.; Shimada, M.
  3. Gene Therapy. 2010, Jan; 17(1): 4-13.
  1. 7.   Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine
  2. Klinman, D. M.; Yamamoto, M.; Tross, D.; Tomaru, K.
  3. Expert Opinion on Biological Therapy. 2009, Dec; 9(12): 1477-86.
  1. 8.   Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
  2. Jia, B.; Ng, S. K.; DeGottardi, M. Q.; Piatak, M.; Yuste, E.; Carville, A.; Mansfield, K. G.; Li, W. J.; Richardson, B. A.; Lifson, J. D.; Evans, D. T.
  3. Plos Pathogens. 2009 5(1): 1-19.
  1. 9.   Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution
  2. Das, A. T.; Klaver, B.; Centlivre, M.; Harwig, A.; Ooms, M.; Page, M.; Almond, N.; Yuan, F.; Piatak, M.; Lifson, J. D.; Berkhout, B.
  3. Retrovirology. 2008 5 AR 44
  1. 10.   Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
  2. Dobrikova, E. Y.; Broadt, T.; Poiley-Nelson, J.; Yang, X. Y.; Soman, G.; Giardina, S.; Harris, R.; Gromeier, M.
  3. Molecular Therapy. 2008 16(11): 1865-1872.
  1. 11.   Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient
  2. Bausch, D. G.; Feldmann, H.; Geisbert, T. W.; Bray, M.; Sprecher, A. G.; Boumandouki, P.; Rollin, P. E.; Roth, C.; Winnipeg Filovirus Clin Work, G.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S136-S141.
  1. 12.   Complete inactivation of Venezuelan equine encephalitis virus by 1,5-iodonaphthylazide
  2. Sharma, A.; Raviv, Y.; Puri, A.; Viard, M.; Blumenthal, R.; Maheshwari, R. K.
  3. Biochemical and Biophysical Research Communications. 2007, Jun; 358(2): 392-398.
  1. 13.   Live vaccines for human metapneumovirus designed by reverse genetics
  2. Buchholz, U. J.; Nagashima, K.; Murphy, B. R.; Collins, P. L.
  3. Expert Review of Vaccines. 2006, Oct; 5(5): 695-706.
  1. 14.   Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation
  2. Jeevan, A.; McFarl, C. T.; Yoshimura, T.; Skwor, T.; Cho, H.; Lasco, T.; McMurray, D. N.
  3. Infection and Immunity. 2006, JAN; 74(1): 213-224.
  1. 15.   Inhibition of pathologic retinal neovascularization by alpha-defensins
  2. Economopoulou, M.; Bdeir, K.; Cines, D. B.; Fogt, F.; Bdeir, Y.; Lubkowski, J.; Lu, W. Y.; Preissner, K. T.; Hammes, H. P.; Chavakis, T.
  3. Blood. 2005, DEC 1; 106(12): 3831-3838.
  1. 16.   Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice
  2. Liu, J.; He, Y. Y.; Chignell, C. F.; Clark, J.; Myers, P.; Saavedra, J. E.; Waalkes, M. P.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 144-151.
  1. 17.   Effect of CD8(+) lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239 Delta 3-vaccinated rhesus macaques
  2. Schmitz, J. E.; Johnson, R. P.; McClure, H. M.; Manson, K. H.; Wy, M. S.; Kuroda, M. J.; Lifton, M. A.; Khunkhun, R. S.; McEvers, K. J.; Gillis, J.; Piatak, M.; Lifson, J. D.; Grosschupff, G.; Racz, P.; Tenner-Racz, K.; Rieber, E. P.; Kuus-Reichel, K.; Gelman, R. S.; Letvin, N. L.; Montefiori, D. C.; Ruprecht, R. M.; Desrosiers, R. C.; Reimann, K. A.
  3. Journal of Virology. 2005, JUL; 79(13): 8131-8141.
  1. 18.   Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIV(mac)239
  2. Evans, D. T.; Bricker, J. E.; Sanford, H. B.; Lang, S.; Carville, A.; Richardson, B. A.; Piatak, M.; Lifson, J. D.; Mansfield, K. G.; Desrosiers, R. C.
  3. Journal of Virology. 2005, JUN; 79(12): 7707-7720.
  1. 19.   Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis
  2. Brittingham, K. C.; Ruthel, G.; Panchal, R. G.; Fuller, C. L.; Ribot, W. J.; Hoover, T. A.; Young, H. A.; Anderson, A. O.; Bavari, S.
  3. Journal of Immunology. 2005, MAY 1; 174(9): 5545-5552.
  1. 20.   Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers
  2. Mbulaiteye, S. M.; Biggar, R. J.; Pfeiffer, R. M.; Bakaki, P. M.; Gamache, C.; Owor, A. M.; Katongole-Mbidde, E.; Ndugwa, C. M.; Goedert, J. J.; Whitby, D.; Engels, E. A.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, APR 1; 38(4): 474-479.
  1. 21.   Retroviral recombination in vivo: Viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239 Delta vpx/Delta vpr and SIVmac239 Delta nef
  2. Kim, E. Y.; Busch, M.; Abel, K.; Fritts, L.; Bustamante, P.; Stanton, J.; Lu, D.; Wu, S.; Glowczwskie, J.; Rourke, T.; Bogdan, D.; Piatak, M.; Lifson, J. D.; Desrosiers, R. C.; Wolinsky, S.; Miller, C. J.
  3. Journal of Virology. 2005, APR; 79(8): 4886-4895.
  1. 22.   Surprising dependence on postsegregational killing of host cells for maintenance of the large virulence plasmid of Shigella flexneri
  2. Sayeed, S.; Brendler, T.; Davis, M.; Reaves, L.; Austin, S.
  3. Journal of Bacteriology. 2005, APR; 187(8): 2768-2773.
  1. 23.   Quantitative profiling of the detergent-resistant membrane proteome of Iota-b toxin induced Vero cells
  2. Blonder, J.; Hale, M. L.; Chan, K. C.; Yu, L. R.; Lucas, D. A.; Conrads, T. P.; Zhou, M.; Popoff, M. R.; Issaq, H. J.; Stiles, B. G.; Veenstra, T. D.
  3. Journal of Proteome Research. 2005, MAR-APR; 4(2): 523-531.
  1. 24.   Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis
  2. McMurray, D. N.; Allen, S. S.; Jeevan, A.; Lasco, T.; Cho, H.; Skwor, T.; Yamamoto, T.; McFarl, C.; Yoshimura, T.
  3. Tuberculosis. 2005, SEP-NOV; 85(5-6): 295-301.
  1. 25.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel